Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)
Recruiting
Observational Study
Giant Cell Arteritis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 133 (estimated)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Giant cell arteritis (GCA) (or Horton's disease) is a segmental and focal inflammatory arteritis affecting large and medium-sized arteries. Its incidence is estimated at 17.8/100,000 in subjects over 50 years old (and 46/100,000 in subjects over 70 years old). This disease remains a severe pathology due in particular to its vascular, ophthalmological, neurological, cardiac and aortic complications…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient over 18 years of age
* Referred for imaging for an injected MRI for suspected GCA
* Suspicion of GCA based on the presence of three major criteria or two major and one minor criteria defined as follows:
* Major criteria: Age \> 50 years; Headache of recent onset; Cl…
Contacts
No contact information available.